An Approach to Conformational Analysis of Peptides and Proteins in Solution Based on a Combination of Nuclear Magnetic Resonance Spectroscopy and Conformational Energy Calculations
AUTOR(ES)
Gibbons, W. A.
RESUMO
Simple criteria, based on the combined use of nmr spectral parameters and potential energy maps, are proposed for the conformational analysis of polypeptides and proteins. Experimentally determined coupling constants 3JNC for the N-Cα bond are consistent with the Karplus-Bystrov relationship. It is proposed therefore that 3JNC can be used to distinguish (a) between right-and left-handed α-helices, (b) between α-helical, β-pleated sheet, and randomly coiled forms of peptides. The average 3JNC for the random coil is predicted. The criteria proposed are valid for both L- and D-amino acids. Correlation between the Karplus-Bystrov relationship for 3JNC and the peptide conformational potential energy map limits the possible values of the N-Cα dihedral angle ϕ of each amino acid residue in a polypeptide and protein, and therefore presents a method of conformational analysis in solution superior to the use of either nmr or conformational maps alone. Nmr studies of hydrogen bonding or neighboring-group diamagnetic anisotropy reduce the number of possibilities consistent with the above criteria. A suggestion for evaluating the dihedral angle is presented. These criteria are useful provided the coupling constant is not obscured by line broadening.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=283194Documentos Relacionados
- Conformational Studies on Tocinamide and Deaminotocinamide by 220 MHz Nuclear Magnetic Resonance Spectroscopy
- OXYTOCIN AND NEUROHYPOPHYSEAL PEPTIDES: SPECTRAL ASSIGNMENT AND CONFORMATIONAL ANALYSIS BY 220 MHz NUCLEAR MAGNETIC RESONANCE*†
- 300-MHz Nuclear Magnetic Resonance Study of Oxytocin in Aqueous Solution: Conformational Implications
- A conformational analysis of gramicidin S-A by nuclear magnetic resonance.
- Carbon-13 Nuclear Magnetic Resonance Spectroscopy. Structure of the Anticoagulant Warfarin and Related Compounds in Solution